[1] [1] MATTHAY M A, ZIMMERMAN G A, ESMON C, et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group[J]. American Journal of Respiratory and Critical Care Medicine, 2003, 167(7): 1027-1035.

[2] [2] MEYER N J, GATTINONI L, CALFEE C S. Acute respiratory distress syndrome[J]. Lancet, 2021, 398(10300): 622-637.

[3] [3] HERRIDGE M S, TANSEY C M, MATT A, et al. Functional disability 5 years after acute respiratory distress syndrome[J]. The New England Journal Medicine, 2011, 364(14): 1293-1304.

[4] [4] RUBENFELD G D, CALDWELL E, PEABODY E, et al. Incidence and outcomes of acute lung injury[J]. The New England Journal Medicine, 2005, 353(16): 1685-1693.

[5] [5] LU Q Y, YU S F, MENG X Y, et al. MicroRNAs: important regulatory molecules in acute lung injury/acute respiratory distress syndrome[J]. International Journal of Molecular Sciences, 2022, 23(10): 5545-5575.

[6] [6] ZHANG J, LI S, LI L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function[J]. Genomics Proteomics Bioinformatics, 2015, 13(1): 17-24.

[7] [7] PARK J, KIM S, LIM H, et al. Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia[J]. Thorax, 2019, 74(1): 43-50.

[8] [8] MEYER N J, GATTINONI L, CALFEE C S. Acute respiratory distress syndrome[J]. Lancet, 2021, 398(10300): 622-637.

[9] [9] CHEN H I, KAO S J, WANG D, et al. Acute respiratory distress syndrome[J]. Journal of Biomedical Science, 2003, 10(6 Pt 1): 588-592.

[10] [10] THOMPSON B T, CHAMBERS R C, LIU K D. Acute respiratory distress syndrome[J]. The New England Journal Medicine, 2017, 377(6): 562-572.

[11] [11] HU Y, WANG J, ZHOU Y, et al. Peptidomics analysis of umbilical cord blood reveals potential preclinical biomarkers for neonatal respiratory distress syndrome[J]. Life Science, 2019, 236: 116737-116743.

[12] [12] DING D C, SHYU W C, LIN S Z. Mesenchymal stem cells[J]. Cell Transplant, 2011, 20(1): 5-14.

[13] [13] UCCELLI A, MORETTA L, PISTOIA V. Mesenchymal stem cells in health and disease[J]. Nature Reviews Immunology, 2008, 8(9): 726-736.

[14] [14] SAMSONRAJ R M, RAGHUNATH M, NURCOMBE V, et al. Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine[J]. Stem Cells Translational Medicine, 2017, 6(12): 2173-2185.

[15] [15] SPEER C P. Neonatal respiratory distress syndrome: an inflammatory disease?[J]. Neonatology, 2011, 99(4): 316-319.

[16] [16] WORTZEL I, DROR S, KENIFIC C M, et al. Exosome-mediated metastasis: communication from a distance[J]. Developmental Cell, 2019, 49(3): 347-360.

[17] [17] ABBASZADEH H, GHORBANI F, DERAKHSHANI M, et al. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles: a novel therapeutic paradigm[J]. Journal of Cellular Physiology, 2020, 235(2): 706-717.

[18] [18] SU C F, KAO S J, CHEN H I. et al. Acute respiratory distress syndrome and lung injury: pathogenetic mechanism and therapeutic implication[J]. World Journal of Critical Care Medicine, 2012, 1(2): 50-60.

[19] [19] LIU C, XIAO K, XIE L X. Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome[J]. Frontiers in Cell and Developmental Biology, 2022, 10: 951764-951781.

[20] [20] GURUNATHAN S, KANG M H, KIM J H. A comprehensive review on factors influences biogenesis, functions, therapeutic and clinical implications of exosomes[J]. International Journal of Nanomedicine, 2021, 16: 1281-1312.